An analysis of affected children identifies mutations in several genes previously implicated in adult-onset disease.
Researchers have identified many genetic causes of adult-onset hypertrophic cardiomyopathy, but the role of genetic factors in childhood-onset hypertrophy is not well characterized. In adults, the condition has been linked to mutations in various genes, including those that encode sarcomere proteins.
These investigators examined DNA from 84 unrelated children (63 boys and 21 girls) with isolated, unexplained LV hypertrophy (wall thickness >2 standard deviations above normal-population mean) that was diagnosed before 15 years of age (mean, 7 years; range, 2 days–15 years). A family history of cardiomyopathy was present in 33 children. Forty-six subjects (55%) had at least one gene mutation that could have been responsible for the disorder. De…
Reviewing Author
DisclosuresConsultant/Advisory BoardUnited Healthcare; Element Science; Eyedentifeye, F-Prime
EquityHugo Health; Refactor Health; Element Science
Grant/Research SupportPfizer; Agency for Healthcare Research and Quality; Janssen Research and Development, National Institute of Biomedical Imaging and Engineering; National Heart, Lung, and Blood Institute; Centers for Disease Control and Prevention; National Cancer Institute; American Heart Association
DisclosuresConsultant/Advisory BoardUnited Healthcare; Element Science; Eyedentifeye, F-Prime
EquityHugo Health; Refactor Health; Element Science
Grant/Research SupportPfizer; Agency for Healthcare Research and Quality; Janssen Research and Development, National Institute of Biomedical Imaging and Engineering; National Heart, Lung, and Blood Institute; Centers for Disease Control and Prevention; National Cancer Institute; American Heart Association